Preferential Sensitivity of the <i>EGFR</i> L858M/L861R Mutation to Second-Generation EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer
Chaelin Lee(Seoul National University), Jeonghwan Youk(Korea Advanced Institute of Science and Technology)
Cited by 1
Related Papers
FDG PET for Evaluation of Bone Marrow Status in T-Cell Lymphoma
|Clinical Nuclear Medicine|2018|29
Acquired Resistance Mechanism of EGFR Kinase Domain Duplication to EGFR TKIs in Non–Small Cell Lung Cancer
|Cancer Research and Treatment|2021|9